TICOCIN is indicated in potentially serious Gram-positive infections including those with cannot be treated with other antimicrobial drugs, eg. Penicillins  and cephalosporins.
TICOCIN is useful in the therapy of serious staphylococcal infections in patient who cannot receive or who have failed to respond to the penicillins and cephalosporins or who have infections with staphylococci resistant to other antibiotics.
The effectiveness of Tiecoplanin has been documented in the following infections:
Skin and soft tissue infections, urinary tract infections, lower respiratory tract infections, joint and bone infections, septicaemia, endocarditis and peritonitis related to continuous ambulatory peritoneal dialysis.
TICOCIN may be used for antimicrobial prophylaxis in orthopaedic surgery at risk of Gram-positive infection.